Nicolau Vanessa, Cortes Rui, Lopes Maria, Virgolino Ana, Santos Osvaldo, Martins António, Faria Nancy, Reis Ana Paula, Santos Catarina, Maltez Fernando, Pereira Álvaro Ayres, Antunes Francisco
Escola Nacional de Saúde Pública, Universidade Nova de Lisboa, Av. Padre Cruz, 1600-560 Lisboa, Portugal.
Lean Health Portugal, Campus da Faculdade de Ciências da Universidade de Lisboa, Campo Grande, 1749-016 Lisboa, Portugal.
Healthcare (Basel). 2021 Jun 25;9(7):797. doi: 10.3390/healthcare9070797.
The benefits of antiretroviral therapy (ART) for persons living with HIV (PLWH) are well established. Rapid ART initiation can lead to improved clinical outcomes. Portugal has one of the highest rates of new HIV diagnoses in the European Union, and an average time until ART initiation above the recommendations established by the national guideline according to data from the first two years after its implementation in 2015, with no more recent data available after that. This study aimed to evaluate time from the first hospital appointment until ART initiation among newly diagnosed HIV patients in Portugal between 2017 and 2018, to investigate differences between hospitals, and to understand the experience of patient associations in supporting the navigation of PLWH throughout referral and linkage to the therapeutic process. To answer to these objectives, a twofold design was followed: a quantitative approach, with an analysis of records from five Portuguese hospitals, and a qualitative approach, with individual interviews with three representatives of patient associations. Overall, 847 and 840 PLWH initiated ART in 2017 and in 2018, respectively, 21 days (median of the two years) after the first appointment, with nearly half coming outside the mainstream service for hospital referral, and with observed differences between hospitals. In 2017-2018, only 38.0% of PLWH initiated ART in less than 14 days after the first hospital appointment. From the interviews, barriers of administrative and psychosocial nature were identified that may hinder access to ART. Patient associations work to offer a tailored support to patients' navigation within the health system, which can help to reduce or overcome those potential barriers. Indicators related to time until ART initiation can be used to monitor and improve access to specialized care of PLWH.
抗逆转录病毒疗法(ART)对艾滋病毒感染者(PLWH)的益处已得到充分证实。尽早开始抗逆转录病毒疗法可改善临床结局。葡萄牙是欧盟新艾滋病毒诊断率最高的国家之一,根据2015年实施后的头两年数据,其开始抗逆转录病毒疗法的平均时间高于国家指南建议的时间,此后没有更新的数据。本研究旨在评估2017年至2018年葡萄牙新诊断艾滋病毒患者从首次医院就诊到开始抗逆转录病毒疗法的时间,调查不同医院之间的差异,并了解患者协会在支持艾滋病毒感染者转诊及与治疗过程衔接方面的经验。为实现这些目标,采用了双重设计:一种是定量方法,分析五家葡萄牙医院的记录;另一种是定性方法,对患者协会的三名代表进行个人访谈。总体而言,2017年和2018年分别有847名和840名艾滋病毒感染者开始接受抗逆转录病毒疗法,在首次就诊后21天(两年的中位数)开始,近一半患者来自医院转诊的非主流服务渠道,且各医院之间存在差异。在2017 - 2018年,只有38.0%的艾滋病毒感染者在首次医院就诊后不到14天就开始接受抗逆转录病毒疗法。从访谈中发现了行政和社会心理方面的障碍,这些障碍可能会阻碍获得抗逆转录病毒疗法。患者协会致力于为患者在医疗系统中的转诊提供量身定制的支持,这有助于减少或克服这些潜在障碍。与开始抗逆转录病毒疗法时间相关的指标可用于监测和改善艾滋病毒感染者获得专科护理的情况。